Artelo ART26.12 Osteoarthritis Study: Relief Like Naproxen
Artelo Biosciences (Nasdaq: ARTL) reported new nonclinical data showing its selective FABP5 inhibitor ART26.12 reduced…
#NewsBeep #News #Medication #ART26.12 #ArteloBiosciences #ARTL #CA #Canada #chronicpain #FABP5inhibitor #Health #naproxen #nonclinicalstudy #osteoarthritispain
https://www.newsbeep.com/ca/806962/